CIK 0001831915 · Accelerated filer
Cytek Biosciences, Inc.
Sign in to watch- Ticker
- CTKB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472547526
- Phone
- (877) 922-9835
- Business address
- 47215 LAKEVIEW BOULEVARD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-18 | Jeanmonod Patrik Chief Financial Officer | Shares withheld for taxes | −683 | $14.75 | $10K | 86,632 |
| 2022-11-18 | Jeanmonod Patrik Chief Financial Officer | Option exercise · Restricted Stock Units | −1,752 | 22,202 | ||
| 2022-11-18 | Poirson Allen SVP Bus. and Corp. Dev. | Option exercise | +790 | 42,297 | ||
| 2022-11-18 | Poirson Allen SVP Bus. and Corp. Dev. | Shares withheld for taxes | −308 | $14.75 | $5K | 41,989 |
| 2022-11-18 | Poirson Allen SVP Bus. and Corp. Dev. | Option exercise · Restricted Stock Units | −790 | 10,013 | ||
| 2022-11-14 | Ball Jack Director | Option exercise | +16,000 | $0.40 | $6K | 19,000 |
| 2022-11-14 | Ball Jack Director | Sale | −16,000 | $14.69 | $235K | 3,000 |
| 2022-11-14 | Ball Jack Director | Option exercise · Stock Option (Right to Buy) | −16,000 | 10,666 | ||
| 2022-11-07 | Jiang Wenbin President and CEO | Sale | −20,000 | $14.76 | $295K | 7,785,820 |
| 2022-10-31 | Williams Paul Christopher Chief Operating Officer | Grant or award · Stock option (right to buy) | +24,601 | 24,601 | ||
| 2022-10-31 | Williams Paul Christopher Chief Operating Officer | Grant or award · Restricted Stock Units | +16,108 | 16,108 | ||
| 2022-10-24 | Jeanmonod Patrik Chief Financial Officer | Sale | −3,500 | $15.16 | $53K | 85,563 |
| 2022-10-19 | Yan Ming Chief Technology Officer | Sale | −20,000 | $14.42 | $288K | 8,005,624 |
| 2022-10-07 | Jiang Wenbin President and CEO | Sale | −20,000 | $14.79 | $296K | 7,805,820 |
| 2022-09-26 | Jeanmonod Patrik Chief Financial Officer | Sale | −3,500 | $12.63 | $44K | 89,063 |
| 2022-09-19 | Yan Ming Chief Technology Officer | Sale | −20,000 | $12.42 | $248K | 8,025,624 |
| 2022-09-08 | Jeanmonod Patrik Chief Financial Officer | Option exercise | +40,000 | $0.40 | $16K | 116,132 |
| 2022-09-08 | Jeanmonod Patrik Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −40,000 | 202,661 | ||
| 2022-09-07 | Jiang Wenbin President and CEO | Sale | −20,000 | $12.89 | $258K | 7,825,820 |
| 2022-08-24 | Jeanmonod Patrik Chief Financial Officer | Sale | −3,500 | $13.45 | $47K | 92,563 |
Page 43 of 49 · 980 trades